We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
On November 11, 2020, CR Medicon and Predicine jointly announced that it has entered into a global strategic partnership to assist biomarker-driven clinical trials and novel oncology therapeutics registration in US and China.